However, as detailed in this review, considerable evidence has identified a pathogenic role for MPO-derived oxidants in driving the development of vulnerable atherosclerotic lesions in CAD patients and cardiac complications post-MI. The gene discussed is MPO; the disease is coronary artery disorder.